Through the 90-day period concluding January 02, 2026, Cumberland Pharmaceuticals's top three insider stakeholders include Chairman And Ceo A J Kazimi (5.70Mn shares), Director Kenneth Krogulski (294.62K shares), Director James Jones (44.79K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| A J Kazimi | Chairman And Ceo | 5,700,885 | 01 Dec, 2025 |
| Kenneth Krogulski | 294,622 | 01 Dec, 2025 | |
| Martin E Cearnal | Sr Vp/Chief Commercial Officer | 163,473 | 29 Apr, 2022 |
| Leo Pavliv | Svp And Chief Development Off. | 129,618 | 01 Jul, 2022 |
| Joey A Jacobs | 98,415 | 21 Mar, 2023 | |
| Joseph C Galante | 61,856 | 18 Mar, 2025 | |
| James Jones | 44,793 | 01 Dec, 2025 | |
| James L Herman | Vp And Chief Compliance Office | 38,255 | 26 Mar, 2024 |
| Caroline Young | 33,243 | 01 Dec, 2025 | |
| John M. Hamm | Vp Chief Financial Officer | 20,073 | 18 Mar, 2025 |
| Todd M. Anthony | Vice Pres Organizational Dev | 16,328 | 26 Mar, 2024 |
| Martin S Jr Brown | 8,500 | 18 Mar, 2025 | |
| Chris T. Bitterman | Vice Pres Sales & Marketing | 4,683 | 26 Mar, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Nov, 2025 | Caroline Young | Common Stock | A | 6 | $2.80 | 33,174 | D | L |
| 03 Nov, 2025 | James Jones | Common Stock | A | 13 | $2.80 | 44,504 | D | L |
| 03 Nov, 2025 | A J Kazimi | Common Stock | A | 13 | $2.80 | 5,700,596 | D | L |
| 03 Nov, 2025 | Kenneth Krogulski | Common Stock | A | 68 | $2.80 | 292,663 | D | L |
| 04 Nov, 2025 | Kenneth Krogulski | Common Stock | A | 68 | $2.82 | 292,731 | D | L |
| 04 Nov, 2025 | A J Kazimi | Common Stock | A | 13 | $2.82 | 5,700,609 | D | L |
| 04 Nov, 2025 | Caroline Young | Common Stock | A | 6 | $2.82 | 33,180 | D | L |
| 04 Nov, 2025 | James Jones | Common Stock | A | 13 | $2.82 | 44,517 | D | L |
| 05 Nov, 2025 | Kenneth Krogulski | Common Stock | A | 68 | $2.53 | 292,799 | D | L |
| 05 Nov, 2025 | Caroline Young | Common Stock | A | 6 | $2.53 | 33,186 | D | L |
| 05 Nov, 2025 | James Jones | Common Stock | A | 13 | $2.53 | 44,530 | D | L |
| 05 Nov, 2025 | A J Kazimi | Common Stock | A | 13 | $2.53 | 5,700,622 | D | L |
| 06 Nov, 2025 | James Jones | Common Stock | A | 13 | $2.27 | 44,543 | D | L |
| 06 Nov, 2025 | Kenneth Krogulski | Common Stock | A | 96 | $2.27 | 292,895 | D | L |
| 06 Nov, 2025 | A J Kazimi | Common Stock | A | 13 | $2.27 | 5,700,635 | D | L |
| 06 Nov, 2025 | Caroline Young | Common Stock | A | 3 | $2.27 | 33,189 | D | L |
| 07 Nov, 2025 | Kenneth Krogulski | Common Stock | A | 96 | $2.19 | 292,991 | D | L |
| 07 Nov, 2025 | James Jones | Common Stock | A | 13 | $2.19 | 44,556 | D | L |
| 07 Nov, 2025 | A J Kazimi | Common Stock | A | 13 | $2.19 | 5,700,648 | D | L |
| 07 Nov, 2025 | Caroline Young | Common Stock | A | 3 | $2.19 | 33,192 | D | L |